Atlas FDA

TRANSCYTE

FDA premarket approval P960007/S011 · decided 1999-11-26

Approval details

PMA number
P960007
Supplement
S011
Supplement type
Normal 180 Day Track
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
TRANSCYTE
Generic name
Dressing, wound and burn, interactive
Applicant
Shire Regenerative Medicine
Date received
1999-08-19
Decision date
1999-11-26
Days to decision
99 days
Decision code
APPR
Product code
MGR
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
San Diego, CA
Statement
Approval for changing the frequency of the in-process sterility testing conducted on the device.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.